HCPCS Level II drug code
J2427 — Injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mg
In short
J2427 is the HCPCS Level II code for injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mg. CMS assigns NDCs for Invega Hafyera and Invega Trinza to it. One billing unit is 1 mg. The Medicare Part B payment limit is $13.246 per unit (October 1, 2026 through December 31, 2026).
Code
CMS HCPCS file- Descriptor
- Injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mg
- Short descriptor
- Inj, invega hafyera/trinza
- Code set
- HCPCS Level II, maintained by CMS
- Effective
- Jul 1, 2023
The billing unit is read from the descriptor. Confirm it against the CMS file before billing.
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Units and claim line
Units = dose given ÷ 1 mg. For example, 100 mg is 100 units. Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.
Enter the dose given to build the claim line.
NDCs billed under J2427
CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 6 NDCs to J2427 for Invega Hafyera and Invega Trinza. Billing units per package are CMS’s figures for this code’s unit.
| Drug | NDC (11-digit) | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| Invega Hafyera | 50458-0611-01 | Janssen Pharmaceuticals, Inc. | 3.5 | 1,092 |
| Invega Hafyera | 50458-0612-01 | Janssen Pharmaceuticals, Inc. | 5 | 1,560 |
| Invega Trinza | 50458-0606-01 | Janssen Pharmaceuticals, Inc. | 0.875 | 273 |
| Invega Trinza | 50458-0607-01 | Janssen Pharmaceuticals, Inc. | 1.315 | 410 |
| Invega Trinza | 50458-0608-01 | Janssen Pharmaceuticals, Inc. | 1.75 | 546 |
| Invega Trinza | 50458-0609-01 | Janssen Pharmaceuticals, Inc. | 2.625 | 819 |
J2427: common questions
- Is J2427 a CPT code?
- No. J2427 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
- What NDCs are billed under J2427?
- CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 6 NDCs under J2427, for Invega Hafyera and Invega Trinza. The table on this page shows each one with its billing units per package.
- What is the Medicare payment limit for J2427?
- $13.246 per 1mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.
- What is one billing unit of J2427?
- One unit of J2427 is 1 mg, as stated in the code's descriptor. Units to report = dose given ÷ 1 mg. J-code billing units.